Insider Transactions in Q4 2025 at Ventyx Biosciences, Inc. (VTYX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2025
|
John Nuss CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
12,675
-2.52%
|
$88,725
$7.72 P/Share
|
|
Dec 18
2025
|
Raju Mohan CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
47,345
-1.96%
|
$331,415
$7.72 P/Share
|
|
Dec 17
2025
|
John Nuss CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
34,930
+6.5%
|
-
|
|
Dec 17
2025
|
Raju Mohan CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
116,668
+4.6%
|
-
|
|
Nov 17
2025
|
Roy Gonzales Senior VP, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
1,767
+24.96%
|
$1,767
$1.03 P/Share
|
|
Nov 17
2025
|
Mark S Forman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+33.33%
|
$3,000
$1.03 P/Share
|